Jiangsu Pharmaceutical Association

HOSTING ORGANIZATION

Information Research Center ofInternational Talent, SAFEA

SUPPORTING ORGANIZATION

BIT Group Global Ltd

OPERATING ORGANIZATION

INTERNATIONAL DRUG DISCOVERY SCIENCE & TECHNOLOGY-CHINA 2019

November 15-17, 2019 Nanjing, China

BIT’S 17TH ANNUAL CONGRESS OF

Theme: The Disruptive, Integrate, Innovative, and Development

Welcome Remark

Dear Colleagues and Friends, It is our pleasure to welcome you to the 17th Annual Congress of International Drug Discovery Science and Tech-nology 2019 with a theme of “The Disruptive, Integrate, Innovative, and Development” to be held during November 15-17, 2019 in the beautiful city of Nanjing, China. IDDST as the largest drug R & D event with the longest history in China will further provide you huge opportunities in the innovation hub, Nanjing with huge pool of enthusiastic talents, best Pharmaceutical University and strong Pharmaceutical Industry environment. IDDST- China 2019 will host leading scientists from the academia and industry worldwide, to discuss the latest developments in drug discovery science and technology, diagnosis, clinical trials and therapy. Such a meeting will bring you huge opportunities for you career growth and business development in the largest event of drug discov-ery with up to 400+ Scientific Oral Presentation in 80+ thematic sessions with an allied poster presentation and disruptive technology expositions, new products, new reagents and new methods. The grand event will cover most updated development of drug discovery in the past year from upstream to downstream, from idea to wet lab prac-tice, and from independent discovery to integrative services. The Congress also aims to accelerate the translational medicine for potential innovations in drug discovery into commercialization. More extensive one-to-one matchmaking and industrial networking activities will be provided during the event so as to bring you more opportunities to help your job hunting and entrepreneurship.

We look forward to welcoming the Attendees to this exciting congress which will bring together world leaders, distinguished scientists, overseas Chinese scholars in their respective fields to the fascinating and intellectual environment of Nanjing.

Xiaodan Mei, Ph.D.Executive Chair of IDDST-China 2019President, BIT Group Global Ltd.

SPONSOR

MEDIA PARTNER

Welcome Remark

YEARS2003-2019

Analysis of Attendees

WHO TO EXPECT IN 2019

Past attendees included Industry Leaders, Innovators and Decision Makers, Pharmaceutical/Biotech Executives, World Leading Scientists, Academic Researchers, Hospital Clinicians and Practitioners who are responsible for:★ Research & Discovery ★ Preclinical Development ★ Screening Research ★ Pharmaceutical Development ★ Scientific Affairs Toxicology ★ Product Development ★ Safety ★ Technology ★ Medicine Chemistry ★ Genetics ★ Medical Affairs ★ Traditional Therapies ★Natural Products

Organization Type

Pharma 37%

Biotech 26%

Academia 32%

Services 3%

Non-profit Organizations 1%

Other 1%

Organization Type

CEO 7%

CMO 16%

CSO 17%

Vice President 10%

Director 18%

Professor 22%

Researcher/Scientist 10%

Job Title

Job Title

North America 31%

Europe 23%

Asia 42%

Rest of World 4%

Geographic Location

Geographic Location

Ms. Jessica Cao Tel: 0086-411-84799609-826 Email: jessica@iddst-china.com http: //www.iddst.com/IDDSTCHINA2019/default.asp

Program Layout

Stream 1 Glory HallPre-conference Activities

Stream 2 Master RostrumGreat DD Mind Forum

Stream 3 Pharm Nation TheatreGlobal Drug Innovation Leadership Summit

Stream 4 Dean Forum

Stream 5 Fortune 500 CubeBig Pharma Case Studies

Stream 6 Life Spring ForumCelebrating One Great Scientist’s Outstanding Contributions

Stream 7 Hot Sci-HubBreaking Drug Discovery Research

Stream 8 Lucky StageSmart Screening for Hits to Leads

• Stream 701: Molecular Cell Biology and Drug Discovery • Stream 702: Drug Discovery Toxicology Technologies • Stream 703: Recent Advances in Pharmacology • Stream 704: Biophysical Chemistry and Drug Discovery • Stream 705: Neurobiology and Drug Discovery • Stream 706: Oncology and Drug Discovery

• Stream 801: Novel Technology for Drug Discovery • Stream 802: Genomics and Drug Discovery

Stream 9 Target KingdomEmerging Drug Targets

Stream 10 Discovery AI BoxAI in Drug Discovery

• Stream 901: Novel TherapeuticTargets• Stream 902: Molecular Targets and Cancer • Stream 903: CNS and Neurodegenerative Targets • Stream 904: Kinase Inhibitor Discovery • Stream 905: Ion Channel and GPCR Targets

• Stream 1001: Data Driven AI in Target Discovery • Stream 1002: Artificial Intelligence in Drug Design

Stream 11 New Biomodality BayInnovative Bio-drugs

Stream 12 IO CampImmunotherapy Summit

• Stream 1101: New Therapeutic Proteins and Peptide • Stream 1102: Gene Therapeutics: Oligonucleotides, Nucleic Acid Drugs and mRNA Drugs • Stream 1103: Cell Therapy and Disease Frontier Technology • Stream 1104: Novel Antibodies and Antibody-drug Conjugates • Stream 1105: Novel Vaccine and Disease

• Stream 1201: Immune Checkpoints and Immuno-therapy • Stream 1202: Cell based Immunotherapy

Stream 15 Hospital NexusIND Clinical Trials

Stream 16 Bioprocessing SpaceBioprocessing of Biotherapy

• Stream 1501: Clinical Research and Clinical Trials • Stream 1502: Drug Safety, Pharmacovigilance and Risk Management

• Stream 1601: Latest Manufacturing Strategies and Technologies • Stream 1602: Quality Control, Analytics & Regula-tion • Stream 1603: Purification and Recovery Methods and Technologies

Stream 13 IT WorldDD-Informatics Frontier

Stream 14 Bioassay PlatformPreclinical Evaluation

• Stream 1301: Bioinformatics and Computational Biology in Drug Discovery • Stream 1302: Drug Metabolism and Interactions

• Stream 1401: Optimizing Bioassays for Biologics • Stream 1402: Immunogenicity Assessment & Clinical Relevance

Highlights of the Conference

Highlights & Program

www.iddst.com

1 80 SESSIONS

2 800+ Global Participants

3 400+ Oral Presentations

4 50+ Exhibitors

5 30+Projects Matchmaking

6 100+ Poster

7 Welcome Banquet

8 Optional Tours

Stream 17 Disruptive UniverseDisruptive DD Tech

Stream 18 Natural GardenNatural Products & TCM

• Stream 1701: Innovations in Drug Delivery System and Technology • Stream 1702: Nanotechnologies for Drug Discov-ery • Stream 1703: Structural Biology in Drug Discovery • Stream 1704: Medicinal Chemistry and Drug Discovery

• Stream 1801: Natural Products Drug Discovery and Therapy • Stream 1802: Bioactive Molecules from Plant and Herb Marine organism

Stream 19 Design StudioSmart Drug Design

Stream 20 Molecule PipelineMajor Disease INDs

• Stream 1901: Drug Design and Synthesis • Stream 1902: Novel Small Molecule Drugs Discov-ery and Design

• Stream 2001: Cancers/Tumors • Stream 2002: CNS and Neurodegenerative Disorders • Stream 2003: Inflammation and Immune Diseases • Stream 2004: Diabetes, Obesity and Metabolic Diseases • Stream 2005: Infectious Diseases and Infections

Stream 21 Scarcity TunnelOrphan Drug Discovery on Rare Diseases

Stream 22 Funding PoolBio-Investment

• Stream 2101: Clinical Research on Rare Diseases • Stream 2102: Cutting-edge Tech for Diagnosis and Therapeutics

• Stream 2201: Lessons for CEOs and Investors • Stream 2202: Learning from Translational Research Successes to Attract Investment • Stream 2203: Understanding the Newly Expanded Regulatory Reviews of Cross-Border Investments • Stream 2204: Investment & Partnering Opportuni-ties

Stream 23 Partnership BoothOne-to-One Drug Discovery Collaboration

Stream 24 CRO/CMO GatewayDrug Discovery Integrative Services

• Stream 2301: Sino-EU and USA Drug Innovation Collaboration • Stream 2302: Trilateral Drug Innovation Collabora-tion among China, Japan and Korea • Stream 2303: Sino-German Drug Innovation Collaboration • Stream 2304: Academic CRO/Industrial Collabora-tions

• Stream 2401: Perspectives on Partnerships • Stream 2402: Scientific Research Outsourcing • Stream 2403: Clinical Trial, Production & Transportation Outsourcing • Stream 2404: R&D-CRO Collaboration & Business Models • Stream 2405: CRO/CMO Selection and Management • Stream 2406: How to Managing a Complex CMO Network?

Stream 25 Wall Free xLabOpen Drug Innovation

Stream 26 Petrel NestOverseas Chinese Pharm Scientist Forum

• Stream 2501: Open Drug Innovation Strategy • Stream 2502: Accessible Compound Libraries • Stream 2503: Opening Design and Synthesis Lab • Stream 2504: Non-profit Public-private Partnerships

• Stream 2601: Policies and Development of Local Pharmaceutical Industry• Stream 2602: Overseas Chinese Drug Innovation • Stream 2603: New Models of Cooperation • Stream 2604: Investment and Financing

Stream 27 Youth ClubYoung Doctoral Scientist Consortium

Stream 28 R & B BioPost-Silkroad DD Partnership Forum

• Stream 2701: Frontier Research in Drug Discovery • Stream 2702: Emerging Drug Discovery Technolo-gy • Stream 2703: New Drug R & D Pipelines for Major Diseases • Stream 2704: Smart Drug Delivery Systems • Stream 2705: Translational Medicine and Clinical Trial • Stream 2706: New Biodrugs and Therapeutics

• NEW Drug Development Paradigms through IMI ADAPT SMART, IMI and MIT Collaboration Programs • B & R Academia-Industry Bio Partnership Strategies • Future of US-China Biotherapy Partnership • 1-to-1 Networking on Project Matchmaking • New Models in Euro-US Biopharm Collaboration • Roadshow for Bio-Entrepreneurship • Euro-Asia Biopharm Integrative Services • Career Development Along B & R in Drug R & D

Program Layout

www.iddst.com

Dr. Maode Lai Academician of Nationale Akademie der Wissenschafte, President, China Pharmaceutical University, China

Dr. Kaixian ChenAcademician, Shanghai Institute of MateriaMedica, Chinese Academy of Sciences, China

Dr. Henrietta UkwuSenior Vice President, Head of Global Regulatory Affairs, Otsuka, USA

Dr. Sudhakar GaradGlobal Head, Chemical and Pharmaceutical Profiling, Novar-tis, USA

Dr. Qidong YouProfessor and Dean of School of Pharmacy, China Pharmaceuti-cal University, China

Dr. Christopher AbellFellow of the Royal Society, Pro-Vice-Chancellor for Research, The University of Cambridge, UK

Dr. Ge Li Chairman, WuXi AppTec Group, China

Dr. Dieter LubdaDirector, Merck KGaA, Germany

Dr. Yoshinori IkeuraCEO, Axcelead Drug Discovery Partners, Inc., R&D Committee of Japan Pharmaceuticals Manufactur-ers Association, Japan

Dr. Pavel HobzaProfessor, Academy of Sciences of the Czech Republic, Czech Republic

Dr. Qi YinClinical Sciences Therapeutic Area Head, Cardiovascular and Metabol-ic Diseases, Novartis Institutes for BioMedical Research, USA

Dr. Ghotas EvindarChemistry Group Leader, GlaxoSmithKline, USA

Dr. Steffen DenzingerDirector, Strategy and Business Development Process Solutions, Merck Millipore, Germany

Dr. Hong LingVP of Innovation, Head of Pipeline and Scientific Evalua-tion, Qilu Pharmaceuticals, China

Dr. Yan WuVice President, Head of Clinical Operation and Head of Immunol-ogy Development, Hutchison Medi Pharma, China

Dr. Robert BorrisVice-Dean, School of Pharma-ceutical Science and Technolo-gy, Tianjin University, China

Dr. Thomas VorherrDirector Peptide Discovery, Novartis Institutes for BioMedical Research, Switzerland

Dr. Emil FuSenior VP, International Integra-tion, Fountain Medical Develop-ment, China

Dr. Zhenhong LiSenior Director, REGENXBIO Inc., USA

Dr. Ningsun Yang Distinguished Research Fellow and Chair Professor, Academia Sinica, Taiwan

Dr. Weiyi ZhangDirector, External Innovation China Research Beyond Borders, Corporate Discovery Research, Boehringer-Ingel-heim Pharma, China

Dr. Gert FrickerDirector, Institute of Pharmacy and Molecular Biotechnology, Ruprecht-Karls University, Germany

Dr. Stephan ZahnDirector, Boehringer Ingelheim RCV GmbH & Co KG, Austria

Dr. Abhay DeshpandeDirector, Global Innovation & Strategy, JRF Global, India

Dr. Cheng ZhangChief Scientific Officer, Gmax BioPharm, China

Dr. Iduna Jutta FichtnerCOO, EPO-Experimental Pharmacology and Oncology GmbH, Germany

Renowned Speakers

www.iddst.com

RENOWNED SPEAKERS

1 Executives of Top 500 Pharma Companies

2 Presidents and Deans of Top 100 Universities

3 Academicians

4 Renowned Scientists

EXHIBITION AND POSTERThis conference provides an unparalleled marketing opportunity for your company in order to get connection with industry decision-makers. Exhibiting at the right exhibition can be one of the most efficient, effective and successful marketing activities available to you.

Exhibition Guidelines:

• Standard Exhibition (3m*2m)• Name of Lintel Board• One Table and Two Chairs

There will be a poster area around conference rooms and every attendee has the same opportunity to apply for a poster for your research result display. Young scientists and students are welcome to apply for these poster opportunities.

Poster Guidelines:

• The regular poster size is 70cm wide x 90cm high.• The text should be black and single spaced so that visitors can see it clearly from Outside

Display Date: November 15-17, 2019 Set up Date: November 14, 2019

Exhibition And Poster

www.iddst.com

CALL FOR

Exhibitors and PostersParticipants Sponsors Partners

POSTER

EX

HIB

ITION

Hotel & Tour Information

www.iddst.com

Nanjing is the capital of Jiangsu Province in East China, running through the city are lower reaches of the Yangtze River whose estuary is not far away. Nanjing enjoys a civilization of over 6000 years and the city itself was found-ed 2500 years ago. Enclosed by mountains and rivers, and located in a strategic place, it boasts picturesque scenery that blends natural landscape with towering modern build-ings, integrating traditional styles with modern civilization. Thus it was known as a unique historic and cultural city to the world.As one of the Four Ancient Capitals, Nanjing is a vital cradle of Chinese civilization and over a long stretch of time, it has been the political and cultural pivot of South China, thus dubbed as the Capital of Ten Ancient Dynas-ties, rich in both cultural heritage and historical relics. Among the landmarks of Nanjing there are the City Wall, the Ming Xiaoling Mausoleum, Dr. Sun Yat-sen Mausole-um, Presidential Palace and Confucius Temple.

Scenery of Nanjing

Holiday Inn Nanjing Qinhuai South Suites Address: No. 12 Mozhou East Road, Jiangning District Nanjing, Jiangsu 211111 China

Reservation: Please contact Ms. Jessica CaoOrganizing Committee of IDDST-China 2019Email: jessica@iddst-china.com

Conference Hotel & Venue:

NANJING

How to Register: http://www.iddst.com/IDDSTCHINA2019/registernow.asp

Registration Information

Conference Price

Only Registration Fee:Includes Full Conference Pass + 3 Days’ Lunch + Coffee Break + Welcome Banquet

Items

Before 7-31-2019

Before 10-31-2019

On-site

Academia Business Academia Business Academia Business

Speaker $1499 $1599 $1799 $1899 - -

Attendee $1599 $1699 $1899 $1999 $2049 $2149

Package A:Includes Registration Fee + Hotel Fee ( 5 star ) + Dinner

Items

Before 7-31-2019

Before 10-31-2019

On-site

Academia Business Academia Business Academia Business

Speaker $2099 $2199 $2399 $2499 - -

Attendee $2199 $2299 $2499 $2599 $2649 $2749

Package B:Includes Registration Fee + Hotel Fee ( 5 star ) + Dinner+ 1 Day Tour of Nanjing （Nov. 17 or 18）

Items

Before 7-31-2019

Before 10-31-2019

On-site

Academia Business Academia Business Academia Business

Speaker $2299 $2399 $2599 $2699 - -

Attendee $2399 $2499 $2699 $2799 $2849 $2949

Team Discounts:3-5 attendees receive a 20% discount6-10 attendees receive a 30% discount10+ attendees receive a 40% discount** Discount is taken from current pricing or on-site pricing but is NOT combinable with promo-tions or offers.

Students Discounts (Only Attendee):Registration for students receive a half discount

Conference Discounts